EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Diagnostic Performance of Serum α-Klotho and FGF-23 in Predicting Obstructive Sleep Apnea Severity: A Novel Biomarker Approach

Nilgun Erten, Demet Aygun iD, Aysen Kutan Fenercioglu iD, Naile Fevziye Misirlioglu iD, Seyma Dumur iD, Ulku Dubus Hos iD, Gonul Simsek, Hafize Uzun iD

Journal of Clinical Medicine · 18.03.2026 · 15 (6) · 2316

DOI: 10.3390/jcm15062316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 18.03.2026. Verfasst von Nilgun Erten und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Istanbul Physical Medicine and Rehabilitation Training and Research Hospital, University of Health Sciences, 34186 Istanbul,…. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Obstructive sleep apnea (OSA) syndrome is characterized by recurrent upper airway obstruction during sleep and is closely associated with systemic inflammation and cardiometabolic risk. α-Klotho and fibroblast growth factor-23 (FGF-23) are emerging biomarkers with potential roles in vascular homeostasis, inflammation, and metabolic regulation. However, their relevance in OSA remains insufficiently elucidated. The aim of this study was to evaluate serum α-Klotho and FGF-23 levels in patients with OSA and to investigate their associations with disease severity. This represents a novel approach that may provide new insights into the pathophysiological mechanisms linking OSA with cardiometabolic risk.

Methods

A total of 133 participants were included in this study and categorized into three groups according to apnea–hypopnea index: 1—simple snoring (n = 44); 2—non-severe OSA (n = 44); and 3—severe OSA (n = 45). Comparisons between two groups were performed using Student’s t-test for normally distributed variables. Comparisons among three or more groups were conducted using one-way ANOVA and the Kruskal–Wallis test. ANCOVA was applied to compare α-Klotho and FGF-23 levels between groups after adjustment for age, BMI, diabetes, hypertension, asthma, COPD, and thyroid disease. The predictive performance of α-Klotho and FGF-23 for severe obstructive sleep apnea was evaluated using ROC curve analysis.

Results

Serum α-Klotho levels decreased significantly with increasing OSA severity (p = 0.001). Serum FGF-23 levels increased significantly across AHI groups (p = 0.001). After adjustment for age, BMI, diabetes, hypertension, asthma, thyroid disease, COPD and vitamin D levels, α-Klotho levels were lower in the severe and non-severe OSA group (p = 0.001, both) compared to the simple snoring group, whereas FGF-23 levels were higher in the severe and non-severe OSA group (p = 0.001; both) compared to the simple snoring group. In predicting the risk of severe OSA compared with non-severe OSA, an α-Klotho cut-off value of 280.3 yielded a sensitivity of 84.44% and specificity of 75%, whereas an FGF-23 cut-off value of 75.5 yielded a sensitivity of 62.2% and specificity of 72.7%.

Conclusions

Serum α-Klotho levels significantly decrease while FGF-23 levels increase in correlation with OSA severity. α-Klotho exhibited superior predictive performance over FGF-23 in identifying severe OSA, suggesting its potential as a more sensitive biomarker for systemic involvement. These results indicate that the α-Klotho/FGF-23 axis is independently associated with OSA and may play a pivotal role in the pathophysiological mechanisms linking intermittent hypoxia to increased cardiometabolic risk.

Schlagwörter

Stichwörter der Autor:innen

FGF-23apnea–hypopnea indexcardiometabolic riskinflammationobstructive sleep apneaα-Klotho

Autor:innen und Institutionen

  • Department of Neurology, Istanbul Physical Medicine and Rehabilitation Training and Research Hospital, University of Health Sciences, 34186 Istanbul, Turkey.
  • Department of Neurology, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Turkey.
  • Department of Family Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, 34098 Istanbul, Turkey.
  • Department of Medical Biochemistry, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Turkey.
  • Department of Neurology, İstanbul Başakşehir Çam and Sakura City Hospital, University of Health Sciences, 34480 Istanbul, Turkey.
  • Department of Physiology, Faculty of Medicine, Istanbul Atlas University, 34408 Istanbul, Turkey.

ORCID-Profile: Demet Aygun, Aysen Kutan Fenercioglu, Naile Fevziye Misirlioglu, Seyma Dumur, Ulku Dubus Hos, Hafize Uzun

Zitieren

APA

Erten, N., Aygun, D., Fenercioglu, A. K., Misirlioglu, N. F., Dumur, S., Hos, U. D., Simsek, G., & Uzun, H. (2026). Comparative Diagnostic Performance of Serum α-Klotho and FGF-23 in Predicting Obstructive Sleep Apnea Severity: A Novel Biomarker Approach. Journal of Clinical Medicine, 15(6), 2316. https://doi.org/10.3390/jcm15062316

Vancouver

Erten N, Aygun D, Fenercioglu AK, Misirlioglu NF, Dumur S, Hos UD, et al. Comparative Diagnostic Performance of Serum α-Klotho and FGF-23 in Predicting Obstructive Sleep Apnea Severity: A Novel Biomarker Approach. Journal of Clinical Medicine. 2026;15(6):2316. doi:10.3390/jcm15062316

BibTeX
@article{Erten2026,
  author = {Erten, Nilgun and Aygun, Demet and Fenercioglu, Aysen Kutan and Misirlioglu, Naile Fevziye and Dumur, Seyma and Hos, Ulku Dubus and Simsek, Gonul and Uzun, Hafize},
  title = {Comparative Diagnostic Performance of Serum α-Klotho and FGF-23 in Predicting Obstructive Sleep Apnea Severity: A Novel Biomarker Approach},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {2316},
  doi = {10.3390/jcm15062316}
}
Kostenlos starten →